Mortality and neurodevelopmental outcome after Staphylococcus aureus bacteremia in infants

Pediatr Infect Dis J. 2007 Dec;26(12):1159-61. doi: 10.1097/INF.0b013e31814620a6.

Abstract

We compared outcomes in infants with methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Infants with methicillin-resistant S. aureus infection had a longer median duration of bacteremia (4.5 versus 1 day, P = 0.01), but no difference in length of hospital stay, mortality, or neurodevelopmental impairment.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacteremia / complications
  • Bacteremia / microbiology
  • Bacteremia / mortality*
  • Child Development / physiology*
  • Female
  • Humans
  • Infant
  • Infant Mortality
  • Infant, Extremely Low Birth Weight
  • Infant, Newborn
  • Infant, Newborn, Diseases / diagnosis
  • Infant, Newborn, Diseases / microbiology
  • Infant, Newborn, Diseases / mortality*
  • Length of Stay
  • Male
  • Methicillin / pharmacology
  • Methicillin Resistance*
  • Psychomotor Disorders / complications*
  • Psychomotor Disorders / diagnosis
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / mortality*
  • Staphylococcus aureus / drug effects*
  • Survival Rate

Substances

  • Anti-Bacterial Agents
  • Methicillin